Christopher M Starr Monopar Therapeutics (MNPR) insider trading activity

MNPR Quotes by TradingView

Christopher M Starr is Director of Monopar Therapeutics. Currently has a direct ownership of 5,173 shares of MNPR, which is worth approximately $179,244. The most recent transaction as insider was on Jul 14, 2025, when has been sold 16,800 shares (Common Stock) at a price of $40.0 per share, resulting in proceeds of $672,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.17K
80.0% 3M change
80.0% 12M change
Total Value Held $179,244

CHRISTOPHER M STARR Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 14 2025
SELL
Open market or private sale
$672,000 $40.0 p/Share
16,800 Reduced 76.46%
5,173 Common Stock
Jul 14 2025
BUY
Exercise of in-the-money or at-the-money derivatives securities
-
16,800 Added 43.33%
21,973 Common Stock
Dec 31 2023
BUY
Exercise of conversion of derivative security
-
2,533 Added 8.92%
25,863 Common Stock
Sep 30 2023
BUY
Exercise of conversion of derivative security
-
2,533 Added 9.79%
23,330 Common Stock
Jun 30 2023
BUY
Exercise of conversion of derivative security
-
2,534 Added 10.86%
20,797 Common Stock
Mar 31 2023
BUY
Exercise of conversion of derivative security
-
2,533 Added 12.18%
18,263 Common Stock
Dec 31 2022
BUY
Exercise of conversion of derivative security
-
2,859 Added 15.38%
15,730 Common Stock
Sep 30 2022
BUY
Exercise of conversion of derivative security
-
2,859 Added 18.18%
12,871 Common Stock
Jun 30 2022
BUY
Exercise of conversion of derivative security
-
2,859 Added 22.21%
10,012 Common Stock
Mar 31 2022
BUY
Exercise of conversion of derivative security
-
2,859 Added 28.56%
7,153 Common Stock
Dec 31 2021
BUY
Exercise of conversion of derivative security
-
751 Added 14.89%
4,294 Common Stock
Sep 30 2021
BUY
Exercise of conversion of derivative security
-
751 Added 17.49%
3,543 Common Stock
Jun 30 2021
BUY
Exercise of conversion of derivative security
-
752 Added 21.22%
2,792 Common Stock
Mar 31 2021
BUY
Exercise of conversion of derivative security
-
751 Added 26.91%
2,040 Common Stock
Dec 31 2020
BUY
Exercise of conversion of derivative security
-
322 Added 19.99%
1,289 Common Stock
Sep 30 2020
BUY
Exercise of conversion of derivative security
-
322 Added 24.98%
967 Common Stock
CMS

Christopher M Starr

Director
Wilmette, IL

Track Institutional and Insider Activities on MNPR

Follow Monopar Therapeutics and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MNPR shares.

Notify only if

Insider Trading

Get notified when an Monopar Therapeutics insider buys or sells MNPR shares.

Notify only if

News

Receive news related to Monopar Therapeutics

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on MNPR